Jan. 15, 2018—The Department of Pathology and Genomic Medicine at Houston Methodist Hospital will be presenting a symposium, “Cytopathology and Small Biopsy: Update in the Texas Medical Center at Houston Methodist Hospital,” at the Houston Methodist Research Institute on Saturday, March 3.
Through didactic lectures, panel discussions, and poster presentations, symposium attendees will learn how the new Bethesda System for Reporting Thyroid Cytopathology assesses the patient’s risk of malignancy regarding thyroid, salivary gland, and urinary tract cytology and small biopsies. By understanding the new reporting system, program attendees will know the risk of malignancy associated with each reporting category or ancillary test and therefore will be better able to more appropriately manage their patients’ care.
Program co-directors are Dina R. Mody, MD, director of cytology laboratories at Houston Methodist Hospital and Bioreference Labs, the Ibrahim Ramzy chair in pathology, and professor of pathology and laboratory medicine, Weill Cornell Medical College; and Mary R. Schwartz, MD, medical director of anatomic pathology, Jack L. Titus chair in pathology, and director of surgical pathology fellowship, all at Houston Methodist Hospital, and clinical professor of pathology and immunology, Baylor College of Medicine.
See events.houstonmethodist.org/cytopathology-update for more information.